Matthew Goetz is a Professor of Oncology, Associate Professor of Pharmacology, Chair of the Mayo Clinic Breast Cancer Disease-Oriented Research Group, and Deputy Director of the Mayo Clinic Breast SPORE. He holds a staff appointment as “Consultant” within the Mayo Clinic Dept. of Oncology, Div. of Medical Oncology. He has been lead investigator in translational studies regarding tamoxifen biomarkers, and he is PI or co-investigator on several NIH-sponsored grants.